Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 06 Oct 2021 for Strongbridge Biopharma plc. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Hilde H. Steineger: trading record in brief
This profile gathers the share dealings of Hilde H. Steineger in Strongbridge Biopharma plc, where the filings describe the role as board member. In total, 4 filings cover trades dated from 14 May 2021 to 5 October 2021.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The newest entry dates from 6 October 2021: a transaction, in Strongbridge Biopharma plc. Typically, a trade is published a median of 3 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Hilde H. Steineger
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations4 total
64,258 sharesOrdinary SharesSEC:0001179110-21-009281:0
17,763 shares@ US$2.0646.2% of flowOrdinary SharesSEC:0001179110-21-009223:0
40,000 shares0Ordinary SharesSEC:0001179110-21-005559:0
18,944 shares@ US$2.3553.8% of flowOrdinary SharesSEC:0001179110-21-005444:0
4 of 4 declarations
